Article/February 27, 2024/6 mins

An unaffordable mess

Who’s to blame for America’s drug pricing crisis? It’s election year, and a prominent jewel in America’s economic crown—its pharma industry—is a front-and-center attraction.  Only, it’s less of a jewel,…

Article/September 7, 2023/11 mins

Marcus and Sarah’s Story

Part 1: An Unwelcome Revelation Let me tell you about Marcus. Marcus was tired. The good kind of tired.  He leaned back and stared at the messy flowcharts sprawled across…

Article/August 18, 2023/9 mins

Ask Me Anything on Patient Engagement

In the first instalment of our Ask Me Anything series, Jeffrey Hirono, Global Head of Insight at Impatient Health, speaks to us about the importance of qualitative data and building trust, in overcoming the challenges that face patient engagement today.

Article/July 6, 2022/3 mins

Learning to go digital: more may not be better

Remember that Khloe Kardashian tweet that put tiny Biohaven’s migraine drug on the map in 2020? It culminated in Pfizer’s $11.6 billion Biohaven buyout last month.  Digital channels gifted smaller…

Article/May 30, 2022/1 min

We must build MVPs

When car designers want to test an idea, they don’t just create focus groups. They don’t stop at market research. They take a much bigger step. The concept car has…

Article/May 30, 2022/1 min

Predictions are a waste of time.

Predictions are a waste of time. They’re arrogant. They’re almost always wrong. You might think that’s a strange thing to say when I’ve just had a good response to my…

Article/March 6, 2022/2 mins

Your customers have bigger priorities.

Allegedly, customer experience (CX) is the absolute priority for almost all of pharma’s commercial departments. Yeah, right. Our efforts are more akin to the 1990s internet. If you were running…

View all articles